|
JAMA Otolaryngology – Head & Neck Surgery |
Comprehensive Chemosensory Psychophysical Evaluation of Self-reported Gustatory Dysfunction in Patients With Long-term COVID-19 |
1 |
Yes |
1/14/2025 |
|
JAMA Surgery |
Comprehensive Review of Chest Tube Management - A Review |
1 |
Yes |
3/9/2025 |
|
JAMA |
Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents |
1 |
Yes |
8/30/2025 |
|
JAMA |
Confronting Health Care's Climate Crisis Conundrum - The Federal Government as Catalyst for Change |
1 |
Yes |
2/4/2025 |
|
JAMA |
Confronting the Delta Variant of SARS-CoV-2, Summer 2021 |
1 |
Yes |
8/26/2024 |
|
Oregon Health & Science University School of Medicine |
Congenital Cardiac Case Conference |
30 |
No |
12/31/2024 |
|
JAMA Oncology |
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) |
1 |
Yes |
4/21/2025 |
|
JAMA Internal Medicine |
Considering Cannabis Use in Differential Diagnosis - A Teachable Moment |
1 |
Yes |
1/4/2025 |
|
JAMA Network Open |
Consumer Views on Using Digital Data for COVID-19 Control in the United States |
1 |
Yes |
6/4/2024 |
|
JAMA Network Open |
Contact and SARS-CoV-2 Infections Among College Football Athletes in the Southeastern Conference During the COVID-19 Pandemic |
1 |
Yes |
11/5/2024 |
|
JAMA Psychiatry |
Contingency Management for Patients Receiving Medication for Opioid Use Disorder |
1 |
Yes |
10/6/2024 |
|
JAMA |
Contraception Selection, Effectiveness, and Adverse Effects - A Review |
1 |
Yes |
12/28/2024 |
|
American Medical Association |
Contracting in Private Practice |
0.25 |
Yes |
2/6/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Arkansas License Renewals |
1.25 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Best Practices for Prescribing |
1.25 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Drug Diversion Prevention |
0.75 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Fundamentals of Addiction and Addiction Treatment |
1.25 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Converging Risks in Anesthesiology: Opioids, Obesity and Obstructive Sleep Apnea |
1.50 |
Yes |
5/8/2026 |
|
JAMA Internal Medicine |
Coronary Artery Lesions at the Same Site Presenting With Different Electrocardiogram Patterns |
1 |
Yes |
5/2/2025 |
|
JAMA Ophthalmology |
Cost Savings From a Policy to Diagnose and Prevent Transmission of Adenoviral Conjunctivitis in Employees of a Large Academic Medical Center |
1 |
Yes |
5/19/2024 |
